NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press Release
Read More
RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease
Press Release
Read More
NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)
Press Release
Read More
Deep phenotyping and spatial immune contexture characterization through a combined multiplex immunofluorescence ( mIF ) approach
Literature
Read More
NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors
Press Release
Read More
Lite Paper: Real-World PD-L1 Testing Data Provides Insight into the Evolving Immuno-oncology Landscape
Blog
Read More
A single-tube NGS assay for simultaneous detection of DNA and RNA biomarkers as a comprehensive solution for clinical management and guiding therapeutic intervention of Ph-like ALL patients
Literature
Read More